Financials
Income statement
| Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
| Total reported revenue | 16.9M | 18.5M | 17.4M | 18.1M |
| Cost of revenue | 1.4M | 851K | 1.2M | 2.5M |
| Gross profit | 15.5M | 17.6M | 16.2M | 15.5M |
| Operating expense | ||||
| Research & development | 27.1M | 32.5M | 24.3M | 25.7M |
| Selling general and admin | 20.9M | 20.7M | 20.9M | 23.4M |
| Other operating expenses | — | — | — | — |
| Operating income | -32.2M | -35.3M | -28.7M | -33.4M |
| Non operating interest income | ||||
| Income | 2.6M | 3.4M | 3.3M | 2.9M |
| Expense | 11.9M | 13.1M | 12.7M | 12.5M |
| Other income expense | 10.4M | 1.4M | 2.4M | -2.8M |
| Pretax income | -31.0M | -43.6M | -35.7M | -45.8M |
| Tax provision | -321K | 90K | 234K | 163K |
| Net income | -30.7M | -44.0M | -36.5M | -46.6M |
| Basic EPS | -0.3 | -0.4 | -0.4 | -0.6 |
| Diluted EPS | -0.3 | -0.4 | -0.4 | -0.6 |
| Basic average shares | 105.4M | 104.8M | 95.7M | 82.6M |
| Diluted average shares | 105.4M | 104.8M | 95.7M | 82.6M |
| EBITDA | -18.3M | -29.7M | -22.4M | -29.3M |
| Net income from continuing op. | -30.7M | -44.0M | -36.5M | -46.6M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |